Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 88070-98-8 Chemical Structure| 88070-98-8

Structure of Bromoenol lactone
CAS No.: 88070-98-8

Chemical Structure| 88070-98-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Bromoenol lactone is an irreversible iPLA2β inhibitor with an IC50 of 7 μM, capable of inhibiting mast cell exocytosis under antigen stimulation without affecting Ca2+ influx, suitable for research on inflammatory responses and phospholipid metabolism.

Synonyms: (6E)-Bromoenol lactone; BEL; HELSS

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Bromoenol lactone

CAS No. :88070-98-8
Formula : C16H13BrO2
M.W : 317.18
SMILES Code : O=C1C(C2=C3C=CC=CC3=CC=C2)CC/C(O1)=C\Br
Synonyms :
(6E)-Bromoenol lactone; BEL; HELSS
MDL No. :MFCD00270871

Safety of Bromoenol lactone

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H314
Precautionary Statements:P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501
Class:8
UN#:3261
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Rat brain astrocytes 5 μM 15 min BEL completely blocked ATP-stimulated DHA release, indicating that DHA release is mediated by iPLA2. Br J Pharmacol. 2003 Jul;139(5):1014-22
ARPE-19 cells 10 μM and 25 μM To investigate the effect of Bromoenol lactone on phagocytosis in ARPE-19 cells. Results showed that BEL pretreatment significantly inhibited rhodopsin degradation and β-hydroxybutyrate release. Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):30
rat retinal neurons 5 μM 30 min Inhibition of iPLA2 to prevent DHA release from phospholipids, thereby blocking DHA's protective effect against oxidative stress-induced apoptosis in retinal neurons J Lipid Res. 2013 Aug;54(8):2236-2246
BV-2 microglial cells 5 μM 6 h BEL significantly decreased the basal levels of 4-HHE in BV-2 microglial cells, indicating the role of iPLA2 in endogenous DHA metabolism. However, BEL only partially inhibited the increase in 4-HHE induced by exogenous DHA or DHA + LPS. J Neuroinflammation. 2018 Jul 9;15(1):202
Barth syndrome patients’ lymphoblasts 2.5 μM 48 h partially restores their cardiolipin homeostasis Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2337-41
normal human epidermal keratinocytes (NHEKs) 10 or 20 µM 30 min To investigate the role of iPLA2 in agonist-induced calcium entry (ACE) in keratinocytes. Results showed that BEL treatment impaired Ca2+ entry in NHEKs. Br J Dermatol. 2008 Jan;158(1):31-7

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.15mL

0.63mL

0.32mL

15.76mL

3.15mL

1.58mL

31.53mL

6.31mL

3.15mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories